Legislation roundup: H shares, futures exchanges and health insurance
November 21, 2019 | BY
Susan MokCSRC allows unlisted H shares to be fully traded and aligns regulation of futures exchanges with international standards while CBIRC tightens its oversight on health insurance business.
Capital Markets
China Securities Regulatory Commission, Business Guidelines on Applications by H Share Companies for Full Tradability of Unlisted Domestic Shares
中国证券监督管理委员会H 股公司境内未上市股份申请"全流通"业务指引
Subject to compliance with relevant laws and regulations and the requirements of policies on the administration of state-owned assets, foreign investment and industry regulation, a holder of unlisted domestic shares may hold consultations at its own discretion to determine the quantity and percentage of its shares the tradability of which it is applying for and shall entrust the H share company to submit a "Full Tradability" application on its behalf.
Further reading
The Outlook for the Mainland and Hong Kong Capital Markets in 2019
Opinions on Further Promoting the Reform of the System for Offering of New Shares
Unloading State-owned Shares: Another Trial Under New Rules
China Securities Regulatory Commission, Measures for the Administration of Futures Exchanges (Draft for Comments)
In order to implement the requirements of the Principles for Financial Market Infrastructure the draft suggests the addition of provisions on the position of the qualified central counterparties of futures exchanges, the requirement that the board of governors establish a risk management committee, net settlement as well as the finality of settlement. Also, foreign futures exchanges and foreign settlement institutions that engage in business in China are required to comply with relevant state provisions.
Further reading
Measures on the Pilot Asset Management Business of Futures Companies
Regulations for the Administration of Futures Trading (Revised)
Insurance
China Banking and Insurance Regulatory Commission, Measures for the Administration of Health Insurance
When an insurance company sells health insurance products, it may not forcibly tie the sale of other products therewith.
An insurance company may not set heredity information, other than the heritable disease history of the insured's family, or genetic testing information as underwriting conditions.
See the digest for more details.
Further reading
PRC Regulations for the Administration of Foreign-funded Insurance Companies (3nd Revision)
China's Pensions Sector Opening Up to Foreign Investment
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now